Navigation Links
Viral Genetics CEO Issues State of the Company Update
Date:2/11/2010

his early, patented work by Dr. Karen Newell has been validated and reinforced by recent research published by other scientists.

We are now working to develop a drug compound based on MDT for victims of glioblastoma, a particularly deadly brain tumor. Our expectation is that this therapy will be used in conjunction with traditional cancer treatments such as chemotherapy and radiation. The drug's role will be to target the cells capable of surviving those treatments. Drug resistance is the leading cause of death among cancer patients. Our hope is that our new approach may provide novel therapy aimed at reversing drug resistance.

Dr. Newell presented her most recent findings on MDT last August at a symposium of neurosurgeons and neuro-oncologists. The conference was hosted by the Department of Neurosurgery at the University of Colorado Denver School of Medicine.

Viral Genetics has created a wholly owned subsidiary called MetaCytoLytics, Inc., dedicated to advancing new treatments based on MDT.

Detecting Disease Through Saliva

Research continues on one of our first areas of interest—a kit that enables physicians to detect disease through a serum or saliva test. Our initial work, based on a thymus nuclear protein compound (TNP), determined that serum can be used as a "litmus" test indicating illness. Recent work suggests that saliva may provide an alternative to serum for detection. The priority for Viral Genetics' research team is to enhance the test's sensitivity and specificity for detecting a variety of illnesses.

The Science Behind the Treatments

Explaining Our Targeted Peptide Technology (TPT)

TPT is an acronym for "targeted peptide technology," a line of research developed by our lead scientist Dr. M. Karen Newell. This tech
'/>"/>

SOURCE Viral Genetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. CDC Foundation Launches Viral Hepatitis Action Coalition
2. Viral Genetics Files 2009 3rd Quarter Consolidated Financials and Information Statement at Pinksheets.com
3. Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
4. Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
5. Noninvasive Breath Test Predicts Survival in Patients with Viral Hepatitis
6. Trana Discovery and Southern Research Institute Find Bioactive HIV Antiviral Compounds
7. Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
8. In Vitro Study of Adamas Pharmaceuticals Triple Combination Antiviral Drug Therapy Shows Activity Against Drug-Resistant Influenza Viruses
9. Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
10. ANA773 Demonstrates Significant Antiviral Response in Early Clinical Trial in Hepatitis C Patients
11. Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... OAKS, Calif. , Sept. 2, 2014 ... today announced the submission of a Marketing ... Agency (EMA) via the centralized procedure for ... of adults with melanoma that is regionally ... oncolytic immunotherapy administered as an intralesional injection ...
(Date:9/2/2014)... Bluegrass Vascular Technologies (BVT), ... lifesaving devices and methods for vascular access procedures, ... Niederauer , a seasoned senior medical device executive, ... of Series A financing, BVT is focused on ... Catheter System, a proprietary system that allows physicians ...
(Date:9/2/2014)... , Sept. 2, 2014  Soligenix, Inc. ... clinical stage biopharmaceutical company focused on developing ... there remains an unmet medical need, as ... therapeutics, announced today promising preliminary results from ... vaccine RiVax™, in a non-human primate (NHP) ...
Breaking Medicine Technology:Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To The European Medicines Agency 2Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To The European Medicines Agency 3Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To The European Medicines Agency 4Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To The European Medicines Agency 5Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To The European Medicines Agency 6Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO 2Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine 2Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine 3Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine 4Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine 5Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine 6Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine 7Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine 8
... Steve Beshear announced yesterday that most of Kentucky,s Medicaid ... state $375 million. In modernizing the state,s Medicaid pharmacy ... by pharmacy benefit managers (PBMs) to lower prescription drug ... said. "Governor Beshear has done the right ...
... the economy recovery continues to lag, employers are looking ... care costs. Running counter to these goals, independent drugstores ... ability to save money by offering lower cost home ... Association (PCMA) said today. "As the economic ...
Cached Medicine Technology:Modernizing Medicaid Rx with 'Innovative' PBM Tools Will Help Kentucky Save $375 Million 2As Economic Recovery Sputters, Independent Drugstores Shouldn't Shoulder Employers With Higher Costs 2
(Date:9/2/2014)... Catalent, the leading global provider of ... biologics and consumer health products, today announced that ... growth, it is to install new automated prefilled ... Supply Center of Excellence. , Catalent already has ... supply facility in Schorndorf, Germany, providing end-to-end clinical ...
(Date:9/2/2014)... Durable Medical Goods manufacture ThermoTek ... and financing company LeaseQ, Inc. to help customers acquire ... late 2012, LeaseQ’s breakthrough finance shopping platform has enabled ... need to run their business. , Said LeaseQ ... the ThermoTek sales team to provide customers faster access ...
(Date:9/2/2014)... Dennis Thompson HealthDay Reporter , ... or at low birth weight are at risk later in ... that increase their risk for heart disease, according to a ... face potential lifetime disadvantages, researchers in both studies -- ... that these obstacles can be overcome. Education appeared to ...
(Date:9/2/2014)... Dallas, Texas (PRWEB) September 02, 2014 ... , “North America Resectoscopes Market Outlook to 2020? ... Resectoscopes market. The report provides value, in millions ... prices (in US dollars) within market segments –, ... Electrodes (Monopolar (Disposable and Reusable) Electrodes and Bipolar ...
(Date:9/2/2014)... announce that the following papers will be published ... 2014, taking place in Barcelona, Spain, 30 August ... biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting ... single-blind, non-inferiority trial, Windecker et al , ... polymer, and drug release have improved clinical outcomes ...
Breaking Medicine News(10 mins):Health News:Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions 2Health News:Medical Technology Manufacturer ThermoTek Announces New Partnership with LeaseQ.com to Help More Customers Acquire Equipment Faster and Cheaper 2Health News:Preterm or Small Birth Tied to Long-Term Risks to Heart, Brain 2Health News:Preterm or Small Birth Tied to Long-Term Risks to Heart, Brain 3Health News:North America Resectoscopes & Bronchoscopes Market (Revenue, Volume & Company Share) to 2020 Report Available at MarketOptimizer.org 2Health News:North America Resectoscopes & Bronchoscopes Market (Revenue, Volume & Company Share) to 2020 Report Available at MarketOptimizer.org 3Health News:North America Resectoscopes & Bronchoscopes Market (Revenue, Volume & Company Share) to 2020 Report Available at MarketOptimizer.org 4Health News:The Lancet: European Society of Cardiology Congress 2014 media alert 2
... of more people in China than tuberculosis or AIDS in ... Health Ministry has prompted a// crackdown in the capital and ... fake and poor quality rabies vaccines are to be blamed, ... to report findings on fake vaccines to the central government ...
... of anti-rejection medications for kidney transplant recipients. It is ... effects. ,Long-term steroid use is associated with ... patients. Therefore, much effort has been made toward decreasing, ... clinical organ transplantation. ,A new study in ...
... A study was conducted on women in their 70's ... older women. This study followed nearly 12,000 women in// ... moderate alcohol intake (1-2 drinks/day for 3-6 days/week, depending on ... survival in older women. ,This study was published ...
... A new study published today in the open access journal ... the HIV infected numbers //of people in India are flawed ... Lalit Dandona and his colleagues, who are from the Administrative ... the Researchers from Nizam’s Institute of Medical Sciences in Hyderabad. ...
... the University of Cambridge have discovered a rare genetic ... identified// who suffer no physical pain because of ... affected, are noticed to be numb to pain.Three related ... disorder. , ,The research has been published by ...
... Tatiana Hogan, who were born in late October, //could be ... Thursday – doctors reported on Wednesday, who added that no ... them. ,After the premature birth of the girls ... growing at a normal rate, weighing around 6.6 pounds and ...
Cached Medicine News:
Used for implantation to reinforce soft tissue in the repair of a hernia or body wall defect. Supplied sterile in peel-open packages. Intended for one-time use....
... is a new, portable, light weight, high ... dermatology, cosmetic and plastic surgery, general surgery, ... skin resurfacing, it is the smallest, yet ... the market. It provides an ideal treatment ...
... Surgical Laser System is designed for ... high-power, dual-wavelength system designed for urology, ... surgery, neurosurgery, pulmonary surgery and gastroenterology ... vaporizes and coagulates tissue with minimal ...
... biolitecs sophisticated Ceralas D15/810 diode laser is ... ideal for many soft tissue applications. With ... D15/810 features a flexible fiber optic delivery ... irrigated or dry environments alike.,Compact and portable, ...
Medicine Products: